OP
RPRX icon

Oslo Pensjonsforsikring’s Royalty Pharma RPRX Stock Holding History

Oslo Pensjonsforsikring’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.8K Sell
870
-1,104
-56% -$57.5K 0.01% 440
2026
Q1 		$94.7K Buy
+1,974
New +$86.5K 0.01% 395

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oslo Pensjonsforsikring's RPRX Position: Q2 2026 in Review

Oslo Pensjonsforsikring reduced its Royalty Pharma (RPRX) stake by 56% in Q2 2026, selling an estimated $57.5K and leaving 870 shares worth $48.8K. The position accounts for 0.01% of the portfolio, ranked #440.

Oslo Pensjonsforsikring first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $94.7K in Q1 2026. 640 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Oslo Pensjonsforsikring held 870 shares of Royalty Pharma worth $48.8K as of Q2 2026.
  • Oslo Pensjonsforsikring sold 1,104 Royalty Pharma shares in Q2 2026, an estimated $57.5K.
  • Royalty Pharma made up 0.01% of Oslo Pensjonsforsikring's portfolio in Q2 2026, its #440 holding.
  • Oslo Pensjonsforsikring first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • Oslo Pensjonsforsikring's Royalty Pharma position peaked at $94.7K in Q1 2026.
  • 640 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Oslo Pensjonsforsikring's 13F filing for Q2 2026, filed 31 Jul 2026.